[Federal Register Volume 61, Number 44 (Tuesday, March 5, 1996)]
[Notices]
[Page 8622]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-5021]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
AGENCY: Executive Office of the President, Office of National Drug
Control Policy.
ACTION: The Drug Control Research, Data, and Evaluation Committee
(DCRDEC); Notice of establishment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Director of the Office of National Drug Control Policy has established
the Drug Control Research, Data, and Evaluation Committee (DCRDEC).
The Committee shall provide an avenue of communications by which a
distinguished expert group representing scientific, engineering, law
enforcement, treatment, and associated international scientific
communities may advise the Director of the Office of National Drug
Control Policy (ONDCP) on questions related to national drug control
research. In pursuing this objective, the DCRDEC may operate in
subgroups composed of selected committee members to conduct detailed
examinations of specific issues related to national drug control policy
research.
The Committee will identify gaps in current data collection to
improve the generation of accurate and useful information on which to
base national drug control policy. It will function solely as an
advisory body and in compliance with the provisions of the Federal
Advisory Committee Act. Its charter will be filed under the Act fifteen
(15) days from the date of this publication.
The Committee will be comprised of approximately fourteen members.
The full DCRDEC subgroup will meet approximately twice per year in
plenary sessions at the convenience of the Director of the ONDCP. In
addition, various sub-committees meet periodically throughout the year.
FOR FURTHER INFORMATION CONTACT: Comments and questions regarding the
Drug Control Research, Data, and Evaluation Committee (DCRDEC) should
be directed to Mr. Edward H. Jurith, General Counsel, Office of
National Drug Control Policy, Executive Office of the President, 750
17th Street, N.W., Washington, D.C. 20500, (202) 395-6709.
Signed at Washington, DC, this 26th day of February, 1996.
Edward H. Jurith,
General Counsel.
[FR Doc. 96-5021 Filed 3-4-96; 8:45 am]
BILLING CODE 3180-02-P
